Forte Biosciences Inc. (FBRX) is a clinical-stage biopharmaceutical firm focused on advancing novel therapeutics for dermatological conditions, with a primary emphasis on eczema. Based in Torrance, California, the company leverages a proprietary platform underpinned by cutting-edge genetic and biological research to develop targeted treatment solutions that improve patient outcomes. As Forte navigates critical clinical trials and regulatory pathways, it is well-positioned to capture a substantial share of the dermatology market, presenting compelling investment opportunities within the biotechnology landscape. Show more

Location: 3060 PEGASUS PARK DRIVE, DALLAS, TX, UNITED STATES, 75247, Dallas, TX, 75247, USA | Website: https://www.fortebiorx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

172.1M

52 Wk Range

$4.90 - $35.62

Previous Close

$29.22

Open

$28.95

Volume

215,740

Day Range

$26.66 - $29.37

Enterprise Value

273.2M

Cash

93.41M

Avg Qtr Burn

-14.0M

Insider Ownership

3.97%

Institutional Own.

96.89%

Qtr Updated

06/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
FB102 Details Celiac Disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FB102 (Anti-CD122 Antibody) Details Alopecia Areata	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FB102 (Anti-CD122 Antibody) Details Vitiligo	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
FB102 Details Graft-versus-host disease	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.